カイノスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/09/06 | 1,132 | 1,133 | 1,121 | 1,121 | -11 | -1% | 1,000 |
| 2024/09/05 | 1,138 | 1,165 | 1,132 | 1,132 | -6 | -0.5% | 2,100 |
| 2024/09/04 | 1,155 | 1,158 | 1,133 | 1,138 | -25 | -2.1% | 2,700 |
| 2024/09/03 | 1,160 | 1,175 | 1,160 | 1,163 | +3 | +0.3% | 2,100 |
| 2024/09/02 | 1,175 | 1,184 | 1,155 | 1,160 | -14 | -1.2% | 4,300 |
| 2024/08/30 | 1,151 | 1,175 | 1,150 | 1,174 | +24 | +2.1% | 4,100 |
| 2024/08/29 | 1,162 | 1,162 | 1,150 | 1,150 | -7 | -0.6% | 1,400 |
| 2024/08/28 | 1,162 | 1,166 | 1,155 | 1,157 | -13 | -1.1% | 1,900 |
| 2024/08/27 | 1,170 | 1,170 | 1,166 | 1,170 | ±0 | ±0% | 900 |
| 2024/08/26 | 1,170 | 1,177 | 1,170 | 1,170 | +5 | +0.4% | 1,700 |
| 2024/08/23 | 1,168 | 1,176 | 1,164 | 1,165 | -6 | -0.5% | 2,900 |
| 2024/08/22 | 1,175 | 1,175 | 1,170 | 1,171 | -3 | -0.3% | 1,000 |
| 2024/08/21 | 1,170 | 1,174 | 1,160 | 1,174 | +4 | +0.3% | 700 |
| 2024/08/20 | 1,171 | 1,171 | 1,165 | 1,170 | +5 | +0.4% | 2,000 |
| 2024/08/19 | 1,154 | 1,172 | 1,154 | 1,165 | ±0 | ±0% | 1,800 |
| 2024/08/16 | 1,168 | 1,174 | 1,163 | 1,165 | -3 | -0.3% | 2,200 |
| 2024/08/15 | 1,141 | 1,177 | 1,140 | 1,168 | +30 | +2.6% | 5,700 |
| 2024/08/14 | 1,149 | 1,150 | 1,119 | 1,138 | +6 | +0.5% | 1,500 |
| 2024/08/13 | 1,130 | 1,140 | 1,121 | 1,132 | +2 | +0.2% | 700 |
| 2024/08/09 | 1,125 | 1,137 | 1,115 | 1,130 | +18 | +1.6% | 7,700 |
| 2024/08/08 | 1,125 | 1,125 | 1,106 | 1,112 | -6 | -0.5% | 5,200 |
| 2024/08/07 | 1,100 | 1,131 | 1,100 | 1,118 | +18 | +1.6% | 5,800 |
| 2024/08/06 | 1,117 | 1,142 | 1,100 | 1,100 | +39 | +3.7% | 8,700 |
| 2024/08/05 | 1,152 | 1,176 | 1,061 | 1,061 | -121 | -10.2% | 24,800 |
| 2024/08/02 | 1,176 | 1,190 | 1,167 | 1,182 | -9 | -0.8% | 16,300 |
| 2024/08/01 | 1,191 | 1,201 | 1,188 | 1,191 | +1 | +0.1% | 8,400 |
| 2024/07/31 | 1,198 | 1,213 | 1,187 | 1,190 | -8 | -0.7% | 5,500 |
| 2024/07/30 | 1,197 | 1,214 | 1,194 | 1,198 | +1 | +0.1% | 4,200 |
| 2024/07/29 | 1,225 | 1,225 | 1,194 | 1,197 | -5 | -0.4% | 3,500 |
| 2024/07/26 | 1,214 | 1,227 | 1,200 | 1,202 | -1 | -0.1% | 17,300 |
| 2024/07/25 | 1,166 | 1,245 | 1,159 | 1,203 | +32 | +2.7% | 105,900 |
| 2024/07/24 | 1,175 | 1,220 | 1,170 | 1,171 | -6 | -0.5% | 43,300 |
| 2024/07/23 | 1,181 | 1,181 | 1,171 | 1,177 | ±0 | ±0% | 3,200 |
| 2024/07/22 | 1,181 | 1,195 | 1,171 | 1,177 | -4 | -0.3% | 11,200 |
| 2024/07/19 | 1,174 | 1,185 | 1,169 | 1,181 | -5 | -0.4% | 8,200 |
| 2024/07/18 | 1,181 | 1,194 | 1,179 | 1,186 | +5 | +0.4% | 9,200 |
| 2024/07/17 | 1,188 | 1,188 | 1,171 | 1,181 | -7 | -0.6% | 13,400 |
| 2024/07/16 | 1,191 | 1,194 | 1,182 | 1,188 | -3 | -0.3% | 5,000 |
| 2024/07/12 | 1,187 | 1,192 | 1,181 | 1,191 | +3 | +0.3% | 4,800 |
| 2024/07/11 | 1,190 | 1,195 | 1,184 | 1,188 | -2 | -0.2% | 5,400 |
| 2024/07/10 | 1,189 | 1,191 | 1,186 | 1,190 | -7 | -0.6% | 2,700 |
| 2024/07/09 | 1,185 | 1,197 | 1,181 | 1,197 | +7 | +0.6% | 3,100 |
| 2024/07/08 | 1,184 | 1,192 | 1,180 | 1,190 | +10 | +0.8% | 4,900 |
| 2024/07/05 | 1,186 | 1,186 | 1,180 | 1,180 | -9 | -0.8% | 1,400 |
| 2024/07/04 | 1,183 | 1,193 | 1,183 | 1,189 | +6 | +0.5% | 2,600 |
| 2024/07/03 | 1,180 | 1,195 | 1,180 | 1,183 | -1 | -0.1% | 3,400 |
| 2024/07/02 | 1,180 | 1,185 | 1,178 | 1,184 | +1 | +0.1% | 5,300 |
| 2024/07/01 | 1,183 | 1,194 | 1,180 | 1,183 | +1 | +0.1% | 1,800 |
| 2024/06/28 | 1,199 | 1,199 | 1,182 | 1,182 | -16 | -1.3% | 2,000 |
| 2024/06/27 | 1,193 | 1,200 | 1,174 | 1,198 | -4 | -0.3% | 7,000 |
51～
100
件表示中 / 3585件
類似銘柄と比較する
現在ご覧いただいている「カイノス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| カイノス | 120,300円 | +6.8% | -13.8% | 2.66% | 9.22倍 | 0.78倍 |
|
臨床検査薬の中堅メーカー。生化学、免疫血清学的検査用試薬に重点。共同開発の促進に注力 |
| ＶＩＳ | 90,500円 | +87.8% | +265.7% | 0.00% | 54.35倍 | 2.49倍 |
|
ｍＲＮＡ標的低分子創薬技術を製薬会社に提供。共同創薬研究などによる契約金収入が柱 |
| クリングル | 86,000円 | +240.0% | - | 0.00% | - | 2.80倍 |
|
細胞の増殖、保護、修復などの機能があるＨＧＦタンパク質を用いて、難治性疾患治療薬を開発 |
| キッズバイオ | 11,800円 | - | - | 0.00% | - | 6.21倍 |
|
北大発創薬ベンチャー。バイオ後続品を主力に、乳歯歯髄幹細胞（ＳＨＥＤ）用いた再生医療に力 |
| ＤＥＬＴＡ－Ｐ | 52,300円 | - | - | 0.00% | - | 15.01倍 |
|
創薬ベンチャー。既存の抗がん物質を組み合わせて安全性と有効性を高めた抗がん剤を開発 |
市場注目の銘柄
チャート関連のコラム
